AEON Biopharma Reduces Warrant Exercise Price and Targets ~$6.2M in Gross Proceeds

Filing content

The company reduced the exercise price of its two-year milestone warrants from $0.3221 to $0.20 per share and expects to receive approximately $6.2 million in gross proceeds from the exercise of such warrants by certain holders.